Clinical Trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06124157 2026-03-13

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Phase 3 Recruiting

222 enrolled

Lymphoid

Burkitt Lymphoma

NCT06090669 2026-02-17

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Phase 1 Recruiting

75 enrolled

Classical hematology

Congenital Bone Marrow Failure Syndromes

NCT00061945 2022-05-03

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

302 enrolled 11 charts

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00028002 2020-10-26

Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor

63 enrolled 8 charts

Gastrointestinal Stromal Tumors

NCT00075400 2019-07-24

Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer

26 enrolled 11 charts

GynecologicSarcoma

Recurrent Uterine Sarcoma

NCT00068380 2018-07-11

A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer

17 enrolled 8 charts

Gastrointestinal

Stomach Neoplasms

NCT00074308 2018-06-20

Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers

40 enrolled 10 charts

Dermatologic

Melanoma

NCT00324987 2017-09-14

S0502

Phase 3 Terminated

12 enrolled 13 charts

Gastrointestinal Stromal Tumors

NCT01383447 2017-08-08

Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Phase 1/2 Terminated

2 enrolled 4 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00079313 2017-07-02

Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia

7 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myelomonocytic, Chronic

NCT00045734 2017-05-15

Imatinib Mesylate in Treating Patients With Recurrent Meningioma

23 enrolled 9 charts

CNS

Brain Neoplasms, Meningioma

NCT00039585 2015-04-30

Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00030667 2015-04-15

Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood

CNSGastrointestinalSarcoma

100 enrolled

Neuroblastoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

NCT00009906 2014-12-23

Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Phase 3 Terminated

748 enrolled

Gastrointestinal Stromal Tumors

NCT00470470 2014-12-23

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

30 enrolled 7 charts

Dermatologic

Melanoma

NCT01281865 2014-10-08

Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma

14 enrolled 7 charts

Sarcoma

Sarcoma, Sarcoma, Synovial

NCT00021229 2014-07-31

Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma

Phase 1/2 Terminated

85 enrolled 17 charts

CNS

Astrocytoma, Central Nervous System Neoplasms

NCT00087152 2014-06-09

S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer

27 enrolled 9 charts

Breast

Breast Neoplasms

NCT00022737 2014-02-27

Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia

Phase 3 Completed

220 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00039416 2014-02-25

Imatinib Mesylate in Treating Patients With Myelofibrosis

18 enrolled

Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT01005758 2014-01-10

Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Phase 2 Unknown

180 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00049569 2013-10-08

Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Phase NA Completed

126 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00052949 2013-10-08

Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer

91 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT00028847 2013-09-17

Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia

Phase 1/2 Unknown

60 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00904735 2013-08-12

Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma

Phase 2 Unknown

76 enrolled

CNS

Brain Neoplasms, Meningioma, Central Nervous System Neoplasms

NCT00041197 2013-07-16

Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery

Phase 3 Completed

732 enrolled

Gastrointestinal Stromal Tumors

NCT00015860 2013-06-24

STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia

Blast Crisis, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00031915 2013-06-19

Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

Sarcoma

Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00091078 2013-06-05

Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery

Phase 2 Terminated

96 enrolled

Gastrointestinal Stromal Tumors

NCT00618501 2013-03-26

Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Other hematologic neoplasm

50 enrolled

Leukemia

NCT00068783 2013-02-28

S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

40 enrolled

Dermatologic

Carcinoma, Merkel Cell

NCT00084630 2013-02-28

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

40 enrolled

Sarcoma

Fibrosarcoma, Sarcoma, Dermatofibrosarcoma

NCT00025246 2013-02-20

Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery

89 enrolled

Gastrointestinal Stromal Tumors

NCT00041041 2013-02-20

Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

60 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

NCT00015834 2013-01-24

STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

46 enrolled

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00041340 2013-01-23

Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer

37 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00045188 2013-01-23

Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer

35 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00054431 2013-01-23

Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia

80 enrolled

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase

NCT00030394 2013-01-17

Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

64 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00042952 2013-01-17

Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer

Phase 2 Terminated

32 enrolled

Genitourinary

Dysgerminoma, Testicular Neoplasms, Seminoma

NCT00101088 2013-01-14

Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Phase 1 Terminated

21 enrolled

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT00026169 2013-01-10

Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure

Phase 1 Completed

69 enrolled

Tumor-Agnostic

Neoplasms

NCT00112775 2011-06-07

BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate

Phase 2 Unknown